Vivione Biosciences Inc. (TSXV:VBI) announced that it has entered into an agreement for a private placement of 2,500,000 series A preferred units at $1 per unit for gross proceeds of $2,500,000 with new investor Montalcino Holdings I, LLC on October 15, 2015. It is expected that, subject to final approval by the TSX Venture Exchange, the transaction will close on October 15, 2015.